University Hospital Southampton NHS Foundation Trust is an NHS foundation trust which operates the Southampton General Hospital, the Princess Anne Hospital, Southampton Children’s Hospital, and the New Forest Birth Centre at Ashurst, Hampshire.

During the past decade, University Hospital Southampton NHS Foundation Trust conducted 243 clinical trials. In the 10-year time frame, 243 clinical trials started and 47 clinical trials were completed, i.e. on average, 19.3% percent of trials that started reached the finish line to date. In the past 5 years, 102 clinical trials started and 37 clinical trials were completed. i.e. 36.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Southampton NHS Foundation Trust" #1 sponsor was "University Hospital Southampton NHS Foundation Trust" with 42 trials, followed by "University of Southampton" with 10 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "University College, London" with 6 trials sponsored and "University of Oxford" with 6 trials sponsored. Other sponsors include 220 different institutions and companies that sponsored additional 160 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Southampton NHS Foundation Trust" #1 collaborator was "University Hospital Southampton NHS Foundation Trust" with 14 trials as a collaborator, "University of Southampton" with 12 trials as a collaborator, "Cancer Research UK" with 10 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 8 trials as a collaborator and "Liverpool University Hospitals NHS Foundation Trust" with 7 trials as a collaborator. Other collaborators include 340 different institutions and companies that were collaborators in the rest 264 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Southampton NHS Foundation Trust" are "Coronary Artery Disease" (9 trials), "Prostate Cancer" (5 trials), "Asthma" (4 trials), "Atrial Fibrillation" (4 trials) and "Crohn Disease" (4 trials). Many other conditions were trialed in "University Hospital Southampton NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "University Hospital Southampton NHS Foundation Trust" are "Drug" (131 trials), "Other" (54 trials), "Device" (49 trials), "Biological" (47 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Rituximab" (7 trials), "Cisplatin" (5 trials), "Pembrolizumab" (5 trials) and "Durvalumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Southampton NHS Foundation Trust" are 263 trials for "All" genders, 17 trials for "Male" genders and 15 trials for "Female" genders.

Currently, there are 131 active trials in "University Hospital Southampton NHS Foundation Trust". 5 are not yet recruiting, 84 are recruiting, 40 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 107 completed trials in University Hospital Southampton NHS Foundation Trust, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Southampton NHS Foundation Trust, 34 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 68 trials that are defined as “Not Applicable".